Yi hankali da alamun farko na cutar sankarar bargo kuma kiyaye yara daga barazanar

Cutar sankarar bargo A fannin likitanci, cutar sankarar bargo kuma ana kiranta kansar jini kuma tana cikin nau'in ciwace-ciwacen daji. An rarraba ta zuwa nau'i biyu: m cutar sankarar bargo da kuma cutar sankarar bargo. Bambancin shine gudun..

Cutar sankarar jini da tabin hankali sun banbanta, ba abu daya bane

Mutanen da ba su san komai ba game da cutar sankarar bargo sun fi firgita. Tabbas za su haɗu da sepsis da cutar sankarar bargo. Suna ganin wannan cuta ce. A haƙiƙa, waɗannan cututtuka ne daban-daban guda biyu. Cutar sankarar bargo ta fi sepsis tsanani. Kallo da..

Lusotinib wanda FDA ta amince dashi don maganin myelofibrosis

Rusotinib Allunan (ruxolitinib / Jakafi) don maganin fibrosis na kasusuwa tare da matsakaici ko babban haɗari, gami da fibrosis na kasusuwa na farko, myelofibrosis bayan polycythemia vera, da myelofibrosis bayan idiopathic thro.

Mota NK, immunotherapy

CAR maganin kashe ƙwayoyin cuta na halitta - MD Anderson abokan haɗin gwiwa tare da Takeda

Jami'ar Texas MD Anderson Cibiyar Ciwon daji da Kamfanin Takeda Pharmaceutical Company Limited sun shiga ingantaccen fahimta da izinin bincike don haɓakawa da kasuwa mai karɓar maganin antigen da ke jagorantar kisa na halitta (CAR.

immunotherapy, Maganin kisa na halitta, NK Cell far

CAR-NK far - Sabuwar rigakafin rigakafi a maganin ciwon daji

CAR-NK far wani sabon nau'i ne na rigakafi a cikin maganin ciwon daji. Immunotherapy ya canza yadda ake magance ciwon daji. Immunotherapy ya kasu kashi biyu: daya shine hana rigakafin rigakafi.

Akalabrutunib, Avelumab, CART far, Dabrafanib, Kimiya, Sabbin magunguna, Midostaurin, Niraparib, Pembrolizumab, Tecartus, Tisagenlecleucel, Trametinib, USFDA

Sabbin magunguna na maganin cutar kansa

Yuli 2021: Duba sabbin magunguna a cikin maganin cutar kansa. Kowace shekara, bayan nazarin gwaje-gwajen da wasu muhimman abubuwa, USFDA ta amince da kwayoyi, don haka masu ciwon daji za su iya gaskata cewa magani ya kusa. ..